(Reuters) - The company's shares rose 74 cents, or 4.2 percent, to $18.34.
The committee determined that there were a number of occasions that grant dates were chosen "with the benefit of hindsight as to the price of the company's stock, so as to provide exercise prices lower than the fair market value on the actual measurement date."
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment